The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: July 2018

4D announces publication of data showing potential of single bacterial strains from the human gut microbiota to serve as novel HDAC inhibitors
Pharma & Human Health

4D announces publication of data showing potential of single bacterial strains from the human gut microbiota to serve as novel HDAC inhibitors

JUL 31, 2018
BASF and UC Davis Collaborating to Unlock New Potential in Human Milk Oligosaccharides
Pharma & Human Health

BASF and UC Davis Collaborating to Unlock New Potential in Human Milk Oligosaccharides

JUL 29, 2018
10 Major Topics covered at the International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health (IPC) in Budapest
Biotics and Supplements

10 Major Topics covered at the International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health (IPC) in Budapest

JUL 27, 2018
Finch Therapeutics Expands Its Leading Microbiome IP Estate with Six New Patents
Pharma & Human Health

Finch Therapeutics Expands Its Leading Microbiome IP Estate with Six New Patents

JUL 26, 2018
Advances Along The Gut-Liver-Brain Axis In Alzheimer’s Disease: Why Diet May Be So Impactful
Editor's Choice

Advances Along The Gut-Liver-Brain Axis In Alzheimer’s Disease: Why Diet May Be So Impactful

JUL 26, 2018
Changes in bacterial mix linked to antibiotics increase risk for type 1 diabetes
Pharma & Human Health

Changes in bacterial mix linked to antibiotics increase risk for type 1 diabetes

JUL 26, 2018
Second Genome Appoints Anupama S. Hoey as Chief Business Officer
Finance

Second Genome Appoints Anupama S. Hoey as Chief Business Officer

JUL 24, 2018
Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy
Biotics and Supplements

Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy

JUL 24, 2018
Beiersdorf takes an equity investment into S-Biomedic and collaborates on the skin microbiome
Finance

Beiersdorf takes an equity investment into S-Biomedic and collaborates on the skin microbiome

JUL 20, 2018
Quadrant Biosciences: Researchers Discover Key Link to Understanding Sleep Disorders
Pharma & Human Health

Quadrant Biosciences: Researchers Discover Key Link to Understanding Sleep Disorders

JUL 20, 2018
AgBiome LLC Secures Series C Funding
Finance

AgBiome LLC Secures Series C Funding

JUL 19, 2018